Published in Neurobiol Aging on March 07, 2007
Dexmedetomidine and Delirium in Patients After Cardiac Surgery | NCT02267538
The common inhalation anesthetic isoflurane induces caspase activation and increases amyloid beta-protein level in vivo. Ann Neurol (2008) 2.54
Selective anesthesia-induced neuroinflammation in developing mouse brain and cognitive impairment. Anesthesiology (2013) 1.93
The effects of isoflurane and desflurane on cognitive function in humans. Anesth Analg (2011) 1.88
Perioperative cognitive decline in the aging population. Mayo Clin Proc (2011) 1.66
The inhalation anesthetic isoflurane increases levels of proinflammatory TNF-α, IL-6, and IL-1β. Neurobiol Aging (2010) 1.62
Consensus statement: First International Workshop on Anesthetics and Alzheimer's disease. Anesth Analg (2009) 1.55
Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia. FASEB J (2009) 1.40
Anesthesia, calcium homeostasis and Alzheimer's disease. Curr Alzheimer Res (2009) 1.37
Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar. Br J Anaesth (2013) 1.26
Human Alzheimer and inflammation biomarkers after anesthesia and surgery. Anesthesiology (2011) 1.26
Are anaesthetics toxic to the brain? Br J Anaesth (2011) 1.26
Propofol directly increases tau phosphorylation. PLoS One (2011) 1.25
Anesthetic-induced neurodegeneration mediated via inositol 1,4,5-trisphosphate receptors. J Pharmacol Exp Ther (2010) 1.17
Nitrous oxide plus isoflurane induces apoptosis and increases beta-amyloid protein levels. Anesthesiology (2009) 1.17
Sevoflurane anesthesia in pregnant mice induces neurotoxicity in fetal and offspring mice. Anesthesiology (2013) 1.16
Exposure to general anesthesia and risk of Alzheimer's disease: a systematic review and meta-analysis. BMC Geriatr (2011) 1.16
Neurotoxicity of general anesthetics: cause for concern? Anesthesiology (2009) 1.13
Brief review: anesthetic neurotoxicity in the elderly, cognitive dysfunction and Alzheimer's disease. Can J Anaesth (2010) 1.10
Isoflurane and sevoflurane increase interleukin-6 levels through the nuclear factor-kappa B pathway in neuroglioma cells. Br J Anaesth (2013) 1.05
Are volatile anesthetics neuroprotective or neurotoxic? Med Gas Res (2012) 1.02
Age-dependent postoperative cognitive impairment and Alzheimer-related neuropathology in mice. Sci Rep (2014) 1.02
Surgical incision-induced nociception causes cognitive impairment and reduction in synaptic NMDA receptor 2B in mice. J Neurosci (2013) 1.01
Iatrogenic risk factors for Alzheimer's disease: surgery and anesthesia. J Alzheimers Dis (2010) 1.00
Alzheimer's disease and anesthesia. Front Neurosci (2011) 1.00
Molecular approaches to improving general anesthetics. Anesthesiol Clin (2010) 0.98
Anesthetic propofol attenuates the isoflurane-induced caspase-3 activation and Aβ oligomerization. PLoS One (2011) 0.98
Disruption of hippocampal neuregulin 1-ErbB4 signaling contributes to the hippocampus-dependent cognitive impairment induced by isoflurane in aged mice. Anesthesiology (2014) 0.97
Anesthesia in presymptomatic Alzheimer's disease: a study using the triple-transgenic mouse model. Alzheimers Dement (2011) 0.97
The role of calcium dysregulation in anesthetic-mediated neurotoxicity. Anesth Analg (2011) 0.95
Anesthetic isoflurane increases phosphorylated tau levels mediated by caspase activation and Aβ generation. PLoS One (2012) 0.95
Modulation of murine Alzheimer pathogenesis and behavior by surgery. Ann Surg (2013) 0.94
Anesthesia and incident dementia: a population-based, nested, case-control study. Mayo Clin Proc (2013) 0.93
Inhaled anesthetic potency in aged Alzheimer mice. Anesth Analg (2009) 0.91
Anesthesia, surgery, illness and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.90
Neurodevelopmental consequences of sub-clinical carbon monoxide exposure in newborn mice. PLoS One (2012) 0.90
The common inhaled anesthetic isoflurane increases aggregation of huntingtin and alters calcium homeostasis in a cell model of Huntington's disease. Toxicol Appl Pharmacol (2010) 0.89
General anesthetics and β-amyloid protein. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.89
Isoflurane-induced spatial memory impairment in mice is prevented by the acetylcholinesterase inhibitor donepezil. PLoS One (2011) 0.88
Xenon pretreatment may prevent early memory decline after isoflurane anesthesia and surgery in mice. PLoS One (2011) 0.86
Anesthetic modulation of neuroinflammation in Alzheimer's disease. Curr Opin Anaesthesiol (2011) 0.86
Isoflurane increases neuronal cell death vulnerability by downregulating miR-214. PLoS One (2013) 0.86
The role of anesthetic drugs in liver apoptosis. Hepat Mon (2013) 0.86
MicroPET imaging of ketamine-induced neuronal apoptosis with radiolabeled DFNSH. J Neural Transm (Vienna) (2010) 0.83
Lasting impact of general anaesthesia on the brain: mechanisms and relevance. Nat Rev Neurosci (2016) 0.83
Isoflurane exposure during mid-adulthood attenuates age-related spatial memory impairment in APP/PS1 transgenic mice. PLoS One (2012) 0.83
Propofol and magnesium attenuate isoflurane-induced caspase-3 activation via inhibiting mitochondrial permeability transition pore. Med Gas Res (2012) 0.82
Sevoflurane induces tau phosphorylation and glycogen synthase kinase 3β activation in young mice. Anesthesiology (2014) 0.82
RNA interference-mediated silencing of BACE and APP attenuates the isoflurane-induced caspase activation. Med Gas Res (2011) 0.81
Isoflurane-induced spatial memory impairment by a mechanism independent of amyloid-beta levels and tau protein phosphorylation changes in aged rats. Neurol Res (2012) 0.81
Intranasal insulin prevents anesthesia-induced hyperphosphorylation of tau in 3xTg-AD mice. Front Aging Neurosci (2014) 0.80
Chronic treatment with anesthetic propofol improves cognitive function and attenuates caspase activation in both aged and Alzheimer's disease transgenic mice. J Alzheimers Dis (2014) 0.80
Effects of anesthetic isoflurane and desflurane on human cerebrospinal fluid Aβ and τ level. Anesthesiology (2013) 0.79
The role of hippocampal tau protein phosphorylation in isoflurane-induced cognitive dysfunction in transgenic APP695 mice. Anesth Analg (2014) 0.79
Aspartic acid in the hippocampus: a biomarker for postoperative cognitive dysfunction. Neural Regen Res (2014) 0.78
Effect of the inhaled anesthetics isoflurane, sevoflurane and desflurane on the neuropathogenesis of Alzheimer's disease (review). Mol Med Rep (2015) 0.78
Surgery plus anesthesia induces loss of attention in mice. Front Cell Neurosci (2015) 0.78
Impaired Spatial Learning Memory after Isoflurane Anesthesia or Appendectomy in Aged Mice is Associated with Microglia Activation. J Cell Death (2015) 0.78
Is hydrogen sulfide-induced suspended animation general anesthesia? J Pharmacol Exp Ther (2012) 0.77
miRNA expression profile and involvement of Let-7d-APP in aged rats with isoflurane-induced learning and memory impairment. PLoS One (2015) 0.77
Sevoflurane anesthesia improves cognitive performance in mice, but does not influence in vitro long-term potentation in hippocampus CA1 stratum radiatum. PLoS One (2013) 0.77
Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro. Neurobiol Aging (2015) 0.77
Sevoflurane impairs acquisition learning and memory function in transgenic mice model of Alzheimer's disease by induction of hippocampal neuron apoptosis. Int J Clin Exp Med (2015) 0.77
Intranasal Insulin Prevents Anesthesia-Induced Spatial Learning and Memory Deficit in Mice. Sci Rep (2016) 0.77
Characterization of hippocampal Cajal-Retzius cells during development in a mouse model of Alzheimer's disease (Tg2576). Neural Regen Res (2014) 0.76
Anesthetic effects in Alzheimer transgenic mouse models. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.76
Peripheral surgical wounding may induce cognitive impairment through interlukin-6-dependent mechanisms in aged mice. Med Gas Res (2016) 0.75
Mild Cognitive Impairment and Exposure to General Anesthesia for Surgeries and Procedures: A Population-Based Case-Control Study. Anesth Analg (2017) 0.75
Exposure to general anesthesia and the risk of dementia. J Pain Res (2015) 0.75
Isoflurane anesthesia promotes cognitive impairment by inducing expression of β-amyloid protein-related factors in the hippocampus of aged rats. PLoS One (2017) 0.75
A mutation in β-amyloid precursor protein renders SH‑SY5Y cells vulnerable to isoflurane toxicity: The role of inositol 1,4,5‑trisphosphate receptors. Mol Med Rep (2016) 0.75
Halothane increases neuronal cell death vulnerability by downregulating miR-214 and upregulating Bax. Int J Clin Exp Med (2013) 0.75
Dexmedetomidine Acts via the JAK2/STAT3 Pathway to Attenuate Isoflurane-Induced Neurocognitive Deficits in Senile Mice. PLoS One (2016) 0.75
General anesthesia exposure and risk of dementia: a meta-analysis of epidemiological studies. Oncotarget (2017) 0.75
Effects of long-term infusion of sedatives on the cognitive function and expression level of RAGE in hippocampus of rats. J Anesth (2016) 0.75
Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science (1996) 19.72
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science (2003) 18.18
A specific amyloid-beta protein assembly in the brain impairs memory. Nature (2006) 16.19
Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science (2005) 8.86
Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet (1998) 7.70
Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci (2003) 7.42
Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron (2005) 6.20
Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science (2001) 6.17
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol (2004) 4.63
The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci (2002) 4.27
Adverse cerebral effects of anaesthesia on old people. Lancet (1955) 3.53
Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol Aging (2004) 3.13
Self-assembly of Abeta(1-42) into globular neurotoxins. Biochemistry (2003) 2.85
Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity. Anesthesiology (2004) 2.82
The memory effects of general anesthesia persist for weeks in young and aged rats. Anesth Analg (2003) 2.69
Postoperative cognitive dysfunction in middle-aged patients. Anesthesiology (2002) 2.59
Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem (2005) 2.56
Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways. Neuroscience (2005) 2.52
Long-term impairment of acquisition of a spatial memory task following isoflurane-nitrous oxide anesthesia in rats. Anesthesiology (2004) 2.45
Molecular interactions between inhaled anesthetics and proteins. Pharmacol Rev (1997) 2.31
The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid beta protein levels. Anesthesiology (2006) 2.26
Cognitive dysfunction 1-2 years after non-cardiac surgery in the elderly. ISPOCD group. International Study of Post-Operative Cognitive Dysfunction. Acta Anaesthesiol Scand (2000) 2.21
Alzheimer's disease and cumulative exposure to anesthesia: a case-control study. J Am Geriatr Soc (1994) 2.21
Isoflurane and sevoflurane affect cell survival and BCL-2/BAX ratio differently. Brain Res (2005) 2.03
Tau, tangles, and Alzheimer's disease. Biochim Biophys Acta (2005) 1.82
Structural basis for high-affinity volatile anesthetic binding in a natural 4-helix bundle protein. FASEB J (2005) 1.81
Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J Alzheimers Dis (2005) 1.74
Parkinsonian symptoms during emergence from general anesthesia. Anesthesiology (1995) 1.65
Impaired acquisition of spatial memory 2 weeks after isoflurane and isoflurane-nitrous oxide anesthesia in aged rats. Anesth Analg (2004) 1.60
Volatile anesthetics induce caspase-dependent, mitochondria-mediated apoptosis in human T lymphocytes in vitro. Anesthesiology (2005) 1.55
Promiscuous ligands and attractive cavities: how do the inhaled anesthetics work? Mol Interv (2001) 1.49
Exposure to anaesthetic agents, cognitive functioning and depressive symptomatology in the elderly. Br J Psychiatry (2001) 1.46
Alzheimer's disease and post-operative cognitive dysfunction. Exp Gerontol (2006) 1.41
A case-control study on Alzheimer's disease and exposure to anesthesia. Neurol Sci (2002) 1.38
Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients. Neuroreport (2002) 1.35
Tau phosphorylation and aggregation in Alzheimer's disease pathology. FEBS Lett (2006) 1.35
The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease. Curr Top Med Chem (2006) 1.21
Tau therapeutic strategies for the treatment of Alzheimer's disease. Curr Top Med Chem (2006) 1.16
Progress from Alzheimer's tangles to pathological tau points towards more effective therapies now. J Alzheimers Dis (2006) 1.14
Effects of inhalation anesthetics halothane, sevoflurane, and isoflurane on human cell lines. Life Sci (2005) 1.12
Inhaled anesthetic modulation of amyloid beta(1-40) assembly and growth. Curr Alzheimer Res (2007) 0.92
Volatile anesthetic modulation of oligomerization equilibria in a hexameric model peptide. FEBS Lett (2004) 0.90
Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity. Anesthesiology (2004) 2.82
Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care (2006) 2.26
Isoflurane and sevoflurane affect cell survival and BCL-2/BAX ratio differently. Brain Res (2005) 2.03
Postoperative cognitive decline: where art tau? Anesthesiology (2012) 1.98
Structural basis for high-affinity volatile anesthetic binding in a natural 4-helix bundle protein. FASEB J (2005) 1.81
The common inhalational anesthetic isoflurane induces apoptosis via activation of inositol 1,4,5-trisphosphate receptors. Anesthesiology (2008) 1.79
A conserved behavioral state barrier impedes transitions between anesthetic-induced unconsciousness and wakefulness: evidence for neural inertia. PLoS One (2010) 1.72
Work stress in aging police officers. J Occup Environ Med (2002) 1.68
Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors. Cancer Res (2007) 1.67
Identification of nicotinic acetylcholine receptor amino acids photolabeled by the volatile anesthetic halothane. Biochemistry (2003) 1.66
Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin. Mol Ther (2012) 1.61
Consensus statement: First International Workshop on Anesthetics and Alzheimer's disease. Anesth Analg (2009) 1.55
Weak polar interactions confer albumin binding site selectivity for haloether anesthetics. Anesthesiology (2005) 1.50
Independent cerebral vasoconstrictive effects of hyperoxia and accompanying arterial hypocapnia at 1 ATA. J Appl Physiol (1985) (2003) 1.46
A unitary anesthetic binding site at high resolution. J Biol Chem (2009) 1.34
Multiple binding sites for the general anesthetic isoflurane identified in the nicotinic acetylcholine receptor transmembrane domain. Proc Natl Acad Sci U S A (2010) 1.33
Identification of a fluorescent general anesthetic, 1-aminoanthracene. Proc Natl Acad Sci U S A (2009) 1.29
Anesthesia and the old brain. Anesth Analg (2009) 1.29
Human Alzheimer and inflammation biomarkers after anesthesia and surgery. Anesthesiology (2011) 1.26
Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis. J Control Release (2013) 1.25
m-Azipropofol (AziPm) a photoactive analogue of the intravenous general anesthetic propofol. J Med Chem (2010) 1.21
Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity. J Biol Chem (2006) 1.21
Thermodynamics of xenon binding to cryptophane in water and human plasma. J Am Chem Soc (2007) 1.20
A presenilin-1 mutation renders neurons vulnerable to isoflurane toxicity. Anesth Analg (2008) 1.18
Anesthetic-induced neurodegeneration mediated via inositol 1,4,5-trisphosphate receptors. J Pharmacol Exp Ther (2010) 1.17
Role of international medical graduates providing office-based medical care: United States, 2005-2006. NCHS Data Brief (2009) 1.16
The role of electrostatic interactions in human serum albumin binding and stabilization by halothane. J Biol Chem (2002) 1.15
ORF30 and ORF34 are essential for expression of late genes in murine gammaherpesvirus 68. J Virol (2008) 1.14
Identification of propofol binding sites in a nicotinic acetylcholine receptor with a photoreactive propofol analog. J Biol Chem (2013) 1.14
Ablation of rat TRPV1-expressing Adelta/C-fibers with resiniferatoxin: analysis of withdrawal behaviors, recovery of function and molecular correlates. Mol Pain (2010) 1.12
Sensitive multiplex real-time reverse transcription-PCR assay for the detection of human and animal noroviruses in clinical and environmental samples. Appl Environ Microbiol (2007) 1.10
High throughput modular chambers for rapid evaluation of anesthetic sensitivity. BMC Anesthesiol (2006) 1.10
Inhalational anesthetic-binding proteins in rat neuronal membranes. J Biol Chem (2004) 1.08
Azi-isoflurane, a Photolabel Analog of the Commonly Used Inhaled General Anesthetic Isoflurane. ACS Chem Neurosci (2009) 1.08
Peripheral inflammation increases Scya2 expression in sensory ganglia and cytokine and endothelial related gene expression in inflamed tissue. J Neurochem (2007) 1.07
Prolonged analgesic response of cornea to topical resiniferatoxin, a potent TRPV1 agonist. Pain (2010) 1.06
Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake. Eur J Nucl Med Mol Imaging (2008) 1.06
Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence. Eur J Nucl Med Mol Imaging (2006) 1.06
Short- and long-term effects of handwashing with antimicrobial or plain soap in the community. J Community Health (2003) 1.05
Attitudes toward practice guidelines among intensive care unit personnel: a cross-sectional anonymous survey. Heart Lung (2007) 1.05
Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice. Neurosci Lett (2012) 1.04
Anesthetic potency of two novel synthetic polyhydric alkanols longer than the n-alkanol cutoff: evidence for a bilayer-mediated mechanism of anesthesia? J Med Chem (2005) 1.04
Partitioning of anesthetics into a lipid bilayer and their interaction with membrane-bound peptide bundles. Biophys J (2006) 1.03
Identification of linguistic barriers to diabetes knowledge and glycemic control in Chinese Americans with diabetes. Diabetes Care (2006) 1.02
General anesthetics predicted to block the GLIC pore with micromolar affinity. PLoS Comput Biol (2012) 1.02
On the edge of validation--cancer protease fibroblast activation protein. Mini Rev Med Chem (2008) 1.02
99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule. Eur J Nucl Med Mol Imaging (2007) 1.02
Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity. FEBS Lett (2006) 1.00
Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance. Antimicrob Agents Chemother (2005) 1.00
G protein-coupled receptors as direct targets of inhaled anesthetics. Mol Pharmacol (2002) 1.00
Both ERK/MAPK and TGF-Beta/Smad signaling pathways play a role in the kidney fibrosis of diabetic mice accelerated by blood glucose fluctuation. J Diabetes Res (2013) 0.97
Emergency department waiting times for patients with cancer with febrile neutropenia: a pilot study. Oncol Nurs Forum (2004) 0.97
Differential general anesthetic effects on microglial cytokine expression. PLoS One (2013) 0.97
Relationship of antimicrobial control policies and hospital and infection control characteristics to antimicrobial resistance rates. Am J Crit Care (2007) 0.97
Anesthesia in presymptomatic Alzheimer's disease: a study using the triple-transgenic mouse model. Alzheimers Dement (2011) 0.97
Smoking Status and Metabolic Syndrome in the Multi-Ethnic Study of Atherosclerosis. A cross-sectional study. Tob Induc Dis (2012) 0.96
Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. J Med Chem (2012) 0.94
Isoflurane binds and stabilizes a closed conformation of the leukocyte function-associated antigen-1. FASEB J (2012) 0.94
Modulation of murine Alzheimer pathogenesis and behavior by surgery. Ann Surg (2013) 0.94
Molecular detection of norovirus in sheep and pigs in New Zealand farms. Vet Microbiol (2008) 0.93
Photoactive analogues of the haloether anesthetics provide high-resolution features from low-affinity interactions. ACS Chem Biol (2006) 0.93
NMR structure and dynamics of a designed water-soluble transmembrane domain of nicotinic acetylcholine receptor. Biochim Biophys Acta (2011) 0.93
Overview of the quality standard research of traditional Chinese medicine. Front Med (2011) 0.93
Modulation of a voltage-gated Na+ channel by sevoflurane involves multiple sites and distinct mechanisms. Proc Natl Acad Sci U S A (2014) 0.92
Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain (2003) 0.91
Anesthetic drug development: Novel drugs and new approaches. Surg Neurol Int (2013) 0.91
A high-throughput approach for identification of novel general anesthetics. PLoS One (2009) 0.91
Inhaled anesthetic potency in aged Alzheimer mice. Anesth Analg (2009) 0.91
Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modeling. J Med Chem (2012) 0.90
Volatile anesthetic modulation of oligomerization equilibria in a hexameric model peptide. FEBS Lett (2004) 0.90
Neurodevelopmental consequences of sub-clinical carbon monoxide exposure in newborn mice. PLoS One (2012) 0.90
Small molecule positive allosteric modulation of TRPV1 activation by vanilloids and acidic pH. J Pharmacol Exp Ther (2011) 0.90
Photoaffinity labeling the propofol binding site in GLIC. Biochemistry (2013) 0.89
The common inhaled anesthetic isoflurane increases aggregation of huntingtin and alters calcium homeostasis in a cell model of Huntington's disease. Toxicol Appl Pharmacol (2010) 0.89
Comparative binding character of two general anaesthetics for sites on human serum albumin. Biochem J (2004) 0.89
Polycystin-1 is required for stereocilia structure but not for mechanotransduction in inner ear hair cells. J Neurosci (2011) 0.88
Binding of the volatile general anesthetics halothane and isoflurane to a mammalian beta-barrel protein. FEBS J (2005) 0.88
Image not living up to goal. Anesthesiology (2006) 0.88
Psychological characteristics of frequent short-notice cancellers of diabetes medical and education appointments. Diabetes Care (2005) 0.88
Localization of S100A8 and S100A9 expressing neutrophils to spinal cord during peripheral tissue inflammation. Pain (2007) 0.87
Halothane binding proteome in human brain cortex. J Proteome Res (2007) 0.87
Directed in vitro myogenesis of human embryonic stem cells and their in vivo engraftment. PLoS One (2013) 0.87
Medical student awareness of the Patient-centered Medical Home. Fam Med (2011) 0.87
In vivo activation of azipropofol prolongs anesthesia and reveals synaptic targets. J Biol Chem (2012) 0.87
Structure-activity relationships of 1,4-dihydropyridines that act as enhancers of the vanilloid receptor 1 (TRPV1). Bioorg Med Chem (2008) 0.87
Impact of physiologically based pharmacokinetic modeling and simulation in drug development. Drug Metab Dispos (2013) 0.86